Emergent BioSolutions IncAdd to My Watchlist

EBS:USNew YorkIndustry: Medical-Biomedical/Gene
  • 37.78
  • 0.17  -0.45%
    Today's Change
  • 37.95
    Previous Close
  • Today
    52 Week Low - High
1:55 pm ET 5/5/2016
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding40 million
Market Cap$2 billion
Return on Equity ttm10.36%
Last DividendEBS:US does not pay a dividend
EPS: Year Actual ttm1.331
EPS: Year Est. 12/16 ttm1.960
EPS: Quarterly Actual 12/15 0.78
EPS: Quarterly Est. 3/16 -0.07
Price/Earnings ttm28.39
Relative Price/Earnings1.489
Earnings Growth Rate66.33
Company Description
Emergent BioSolutions, Inc. is a global specialty biopharmaceutical company. The Company develops, manufactures, and delivers a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. Emergent also develops and commercializes therapeutics and other specialty products for hospitals and clinics.
Revenue$523 million
Net Income$63 million
Total Assets$1 billion
Web Sitewww.emergentbiosolutions.com

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!